Jenna L Jeffrey

7PUBLICATIONS
9CO-AUTHORS
Biologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Discovery of a Potent, Orally Bioavailable Small-Molecule Inhibitor of Wildtype KIT with Exceptionally High Kinome Selectivity.

|Jun 05, 2026
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α.

|Apr 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α.

|Oct 21, 2021
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).

Guillaume Mata, Dillon H Miles, Samuel L Drew

|Sep 01, 2020
Discovery of Potent and Selective PI3Kγ Inhibitors.

Samuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty

|Aug 14, 2020
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.

Jenna L Jeffrey, Kenneth V Lawson, Jay P Powers

Pageof 2

Frequent Collaborators

6 joint publications

Kenneth V Lawson

5 joint publications

Guillaume Mata

3 joint publications

Brandon R Rosen

3 joint publications

Ehesan U Sharif